2Said G, Lacroix G, Plante-Bordeneuve V, et al.Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy ( MNGIE ) in four patients including two with a Charcot-Marie-Tooth presentation. J Neurol, 2005, 252: 655-662.
3Takashima H, Nakagawa M, Nakahara K, et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol, 1997, 41: 771-780.
4Zhu D, Kennerson ML, Walizada G, et al. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Neurology, 2005, 65: 496-497.
5Murru MR, Vannelli A, Marrosu G, et al. A novel Cx32 mutation causes X-linked Charcot-Marie-Tooth disease with brainstem involvement and brain magnetic resonance spectroscopy abnormalities. Neurol Sci, 2006, 7 : 18-23.
6Aho TR, Wallace RC, Pitt AM, et al. Charcot-Marie-Tooth disease: extensive cranial nerve involvement on CT and MR imaging, AJNR Am J Neuroradiol, 2004, 25: 494-497.
7Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009)[J]. Neu rology, 2009,72(21 Suppl 4) :S1-S136.
8Betarbet R, Sherer TB, MacKenzie G, et al. Chronic systemic pesticide exposure reproduces features of Parkinson' s disease[J]. Nat Neurosci, 2000,3(12) :1301-1306.
9Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia[J]. Ann Neurol, 1994,36 (3) :348-355.
10Trinh K, Moore K, Wes PD, et al. Induction of the phase Ⅱ detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease[J]. J Neurosci, 2008,28(2): 465-472.
